Navigation Links
Shire to Introduce a New UK Listed Holding Company
Date:4/14/2008

not constitute an offer or invitation to purchase securities.

Morgan Stanley & Co International plc is acting for Shire and Shire Limited and no one else in connection with the Proposals and will not be responsible to anyone other than Shire and Shire Limited for the protections afforded to its clients or for providing advice in relation to the Proposals or the content of this announcement.

THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN INVITATION OR OFFER TO SELL OR THE SOLICITATION OF AN INVITATION OR OFFER TO BUY ANY SECURITY. NONE OF THE SECURITIES REFERRED TO IN THIS ANNOUNCEMENT SHALL BE SOLD, ISSUED, EXCHANGED OR TRANSFERRED IN ANY JURISDICTION IN CONTRAVENTION OF APPLICABLE LAWS.

Notice To United States Residents

This announcement is not an offer of securities in the United States.

The Shire Limited ordinary shares to be issued in connection with the Proposals will not be, and are not required to be, registered with the US Securities and Exchange Commission under the US Securities Act of 1933, as amended, in reliance on the exemption from registration provided by Section 3(a)(10) thereof.

The "SAFE HARBOR" Statement Under the Private Securities Litigation Reform Act of 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Shire's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research; product development including, but not limited to, the successful development of JUVISTA(R) (Human TGFBeta3) and velaglucerase alfa (GA-GCB); manufacturing and commercialization including, but not limited to, the establishment in the market of VYVANSE(TM)(lisdexamfetamine dimesylate) (Attention Deficit and Hypera
'/>"/>

SOURCE Shire PLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Shire and TAP Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis
2. Shire plc: Long Term Incentive Plan
3. Shire plc: IFRS Results for the Year Ending December 31, 2007
4. Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
5. Shire plc: Correction Re Website
6. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
7. Shire Engages Palio
8. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
9. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
10. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
11. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... BOSTON , June 17, 2013 ... billion by 2018, accounting for nearly 16 percent of total ... Drug Report 2013 from Evaluate .   ... this growing segment of the pharmaceutical industry, Evaluate has enhanced ... fact-based orphan drug analysis with data fields for integrated US, ...
(Date:6/17/2013)... CLEVELAND , June 17, 2013 ... healthcare organizations in the country, recovered more than ... with the help of OnBase, Hyland Software,s ... with Hyland to provide a common revenue cycle ... billing systems that were in place for both ...
(Date:6/17/2013)... 2013 Research and ... addition of the "North America Injectable ... Microspheres, & Nanoparticles], Devices [Disposables & Reusable, ... Auto Injectors] & Therapeutics- Forecasts to 2017" ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ...
(Date:6/17/2013)... BEIJING , June 17, 2013 Yongye ... a leading developer, manufacturer, and distributor of crop nutrient ... ("PRC"), announced today that its common stock ... Monday, June 17, 2013 at 7:15 a.m. Eastern Time. ... Yongye,s common stock on Monday, March 18, 2013 following ...
Breaking Biology Technology:Evaluate Launches Enhanced Orphan Drug Intelligence 2Evaluate Launches Enhanced Orphan Drug Intelligence 3Cedars-Sinai Medical Center Recovers More Than $300 million in AR with Hyland Software's OnBase 2Cedars-Sinai Medical Center Recovers More Than $300 million in AR with Hyland Software's OnBase 3North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 2North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 2Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 4
... , , KNOXVILLE and OAK ... Ridge Innovation Valley ( www.knoxvilleoakridge.com ) see the successful test of ... , The Innovation Valley is home to Oak Ridge National Laboratory ... at the forefront of applied carbon fiber research. , ...
... NEW YORK, Dec. 18 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, Inc. ... a pharmaceutical,company dedicated to improving health through the development, ... over the counter ("OTC"),products, today announced that 158 of ... Insurance Catalog (the "2009 NIC"). Of these, 82,are categorized ...
... Department of Energy,s Pacific Northwest National Laboratory have ... the Advancement of Science for their exceptional efforts ... PNNL honorees and the AAAS sections that elected ... Yuehe Lin, chemistry; Philip Rasch, atmospheric and hydrospheric ...
Cached Biology Technology:Boeing Flight Boosts Carbon Fiber Hopes, Knoxville-Oak Ridge Innovation Valley Poised 2Boeing Flight Boosts Carbon Fiber Hopes, Knoxville-Oak Ridge Innovation Valley Poised 3American Oriental Bioengineering Announces the Inclusion of 158 Drugs in China's National Insurance Catalog 2American Oriental Bioengineering Announces the Inclusion of 158 Drugs in China's National Insurance Catalog 36 PNNL scientists elected AAAS fellows 26 PNNL scientists elected AAAS fellows 3
(Date:6/17/2013)... University research associate has received a prestigious fellowship to ... the spread of malaria. , Bart Bryant, research associate ... National Research Service Award Individual Postdoctoral Fellowship, which provides ... State University researcher to receive the award and is ... an award. , Bryant, a university doctoral graduate in ...
(Date:6/17/2013)... populations are declining worldwide and a major cause is ... but a two-year study shows they can also die ... a tolerant carrier host that just spreads the disease. ... controlled experimental conditions, they found at least one strain ... Bd or a chytrid fungus, can be fatal to ...
(Date:6/16/2013)... for female sex workers in India reduce rates of ... University of Toronto study has found. , ... in the southern states of Andhra Pradesh, Karnataka, Maharashtra ... Jha from U of T,s Dalla Lana School of ... Health Research (CGHR), examined the impact of prevention among ...
Breaking Biology News(10 mins):NIH fellowship helps researcher fight malaria, understand mosquito immunity 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2HIV prevention among female sex workers in India reduces HIV and syphilis 2
... polymers (LCP) as a viable tool for use in ... of Alberta researchers, collaborating with colleagues at the Eindhoven ... Netherlands, have shown that LCP, when formed into a ... and patterned on a microscale. The research was published ...
... cell fate decisions for many types of developing cells, according to ... sheds light on a puzzling behavior. For some differentiating stem ... to a new choice. In response to the initial ... different cell types. It often requires a second signal for ...
... with a single injection into a vein holds promise ... University of Florida researchers report. , UF researchers used ... a form of muscular dystrophy that damages the heart. ... and found genes were readily absorbed by heart muscle ...
Cached Biology News:Polymers show promise for lab-on-a-chip technology 2Researchers map out networks that determine cell fate 2Researchers map out networks that determine cell fate 3UF scientists test improved gene therapy method for hereditary heart conditions 2UF scientists test improved gene therapy method for hereditary heart conditions 3UF scientists test improved gene therapy method for hereditary heart conditions 4
... Columns, 10. *SizeSep 400 Spun Columns: For ... pairs in length. - ... in distilled water containing 0.15% Kathon CG/IcP Biocide. ... base pairs. *Extremely useful in the ...
... Light Diagnostics Universal Amplicon Detection ... use in the qualitative detection ... by in vitro nucleic ... only; not to be used ...
... Purification Kit, 25 purifications. Allows ... probesProvides efficient removal of unincorporated CyDye ... with superior yields of labeled cDNA ... of cDNA labeled by either direct ...
... Kit, 50 purifications. Allows rapid purification ... removal of unincorporated CyDye label and ... yields of labeled cDNA probe. ... labeled by either direct incorporation or ...
Biology Products: